Key clinical point: PCI may be considered an acceptable revascularization modality for selected patients with left main coronary artery disease.
Major finding: At 5 years, the primary composite of death, stroke, or MI occurred in 22.0% of patients in the PCI group and 19.2% of patients in the CABG group (P = .13).
Study details: EXCEL, a multicenter analysis of 1,905 patients with left main CAD and site-assessed low or intermediate CAD who were randomized to revascularization with PCI or with CABG, and followed for 5 years.
Disclosures: The EXCEL trial was funded by Abbott Vascular. Dr. Stone disclosed having relationships with numerous device and pharmaceutical companies but had no relevant disclosures for this study.
Stone G et al. TCT 2019. N Engl J Med. 2019 Sep 28. doi: 10.1056/NEJMoa1909406.